ISSN 2398-2942      

Lokivetmab

icanis
Contributor(s):

David Godfrey

Tim Nuttall

Synonym(s): Cytopoint™


Introduction

Name

  • Lokivetmab.

Class of drug

  • Therapeutic caninized monoclonal antibody targeting canine interleukin 31.

Description

Chemical name

  • Lokivetmab is a caninized monoclonal antibody.

Molecular formula

  • Not reported.

Molecular weight

  • Not reported.

Physical properties

  • Ready-to-use sterile liquid in single-dose vials.

Storage requirements

  • Must be stored between 2-8C. Avoid prolonged higher temperatures, direct sunlight and freezing.

Uses

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Indications

  • Canine atopic dermatitis, particularly where:
    • Owners can't or won't give oral medication.
    • Dogs need rapid relief from pruritus.
    • Glucocorticoids Therapeutics: glucocorticoids, oclacitinib Oclacitinib and ciclosporin Ciclosporin result in adverse effects, are ineffective, and/or are contraindicated (eg young animals, infections, demodicosis Skin: demodectic mange, concurrent medication and histocytoma Skin: histocytoma and other neoplasia, etc).
    • Lokivetmab's narrow spectrum of activity means that it best suited to manage pruritus and mild inflammation in early cases of canine atopic dermatitis. Broad-spectrum anti-inflammatory agents should be considered in dogs with chronic inflammatory dermatitis and otitis.
    • Long-term use of lokivetmab should be integrated into a treatment program with skin barrier care, dietary management, allergen specific immunotherapy, and/or topical or systemic antimicrobial and anti-inflammatory treatment according to the needs of each case Therapeutics: allergy management.

Administration

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Pharmacokinetics

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Interactions

With other drugs

  • Caninized monoclonal antibodies should exhibit little to no interaction with systemic or topical drugs.
  • Initial studies showed no interactions with parasiticides, antibiotics, antifungals, corticosteroids, vaccines, allergen specific immunotherapy (for atopic dermatitis), antihistamines, oclacitinib Oclacitinib and ciclosporin Ciclosporin (cyclosporine).

With diagnostic tests

  • Not reported but unlikely.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

MEMBER BENEFIT

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!

 
 
 
 

To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code